Handel nachbörslich: 1.77 0.08 +4.73%

Nrx Pharmaceuticals Inc (NRXP)

Nrx Pharmaceuticals Inc Aktie (NRXP) Neueste Nachrichten

Nrx Pharmaceuticals Inc (NRXP)

Nrx Pharmaceuticals Inc Aktie (NRXP) Neueste Nachrichten

NRX-100 (Ketamine) Reaches Stability Milestone - Contract Pharma

NRx reports stable ketamine for suicidal depression treatment - Investing.com

NRx reports stable ketamine for suicidal depression treatment By Investing.com - Investing.com Canada

NRx Pharmaceuticals Announces Completion of Twelve Months of Stability on the First Manufactured Commercial Scale Lot of NRX-100 (Ketamine) - citybiz

NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announces Completion of Twelve Months of Stability on the First Manufactured Commercial Scale Lot of NRX-100 (Ketamine) - StockTitan

NRx Pharmaceuticals Featured on Psychiatrist.com - citybiz

NRXP stock touches 52-week low at $1.59 amid market challenges - Investing.com

Neumora Therapeutics (NASDAQ:NMRA) Stock Price Up 5.2% - Defense World

Energy Vault Holdings Inc (NRGV) expanding its growth trajectory ahead - SETE News

Market Insights: Recursion Pharmaceuticals Inc (RXRX)’s Notable Gain of 1.65, Closing at 6.76 - The Dwinnex

Rocket Pharmaceuticals’ (RCKT) Buy Rating Reaffirmed at Needham & Company LLC - Defense World

The Significance of Moving Averages in Recursion Pharmaceuticals Inc Inc. (RXRX) Price Performance - The InvestChronicle

Meeder Advisory Services Inc. Increases Stake in Royalty Pharma plc (NASDAQ:RPRX) - Defense World

Market Update: Energy Vault Holdings Inc (NRGV) Sees Negative Movement, Closing at 0.79 - The Dwinnex

NRx Pharmaceuticals’ Innovative Treatments for Depression Gain Spotlight - MSN

Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by State of New Jersey Common Pension Fund D - Defense World

Reneo Pharmaceuticals Inc (RPHM) rating downgrades by Leerink Partners - Knox Daily

Reneo Pharmaceuticals executive buys shares worth over $484k By Investing.com - Investing.com Canada

Recursion Pharmaceuticals Inc’s latest rating changes from various analysts - Knox Daily

A look into Recursion Pharmaceuticals Inc (RXRX)’s deeper side - SETE News

Do you want to know where to find good stock? Take a look at Recursion Pharmaceuticals Inc’s (NASDAQ:RXRX) Sentiment Analysis – US Post News - US Post News

January 2027 Options Now Available For NRG Energy - Nasdaq

Metric Analysis: Royalty Pharma plc (RPRX)’s Key Ratios in the Limelight - The Dwinnex

Market Resilience: Reneo Pharmaceuticals Inc (RPHM) Finishes Weak at 1.31, Down -7.09 - The Dwinnex

NRx Pharmaceuticals’ Innovative Treatments for Depression Gain Spotlight - MyChesCo

Forsta AP Fonden Increases Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - Defense World

Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Royal London Asset Management Ltd. - Defense World

Needham & Company LLC Reiterates Buy Rating for Neumora Therapeutics (NASDAQ:NMRA) - Defense World

Neumora Therapeutics' (NMRA) "Buy" Rating Reaffirmed at Needham & Company LLC - MarketBeat

NRG Energy, Inc. (NRG): A Very Important AI Stock According to BlackRock - Insider Monkey

NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Featured on Psychiatrist.com - Morningstar

NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Featured on Psychiatrist.com - PR Newswire

NRx Pharmaceuticals and HOPE Therapeutics Announce Participation at the H.C. Wainwright 26th Annual Global Investment Conference September 9-11, 2024 - citybiz

NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) and HOPE Therapeutics, Inc. Announce Participation at the H.C. Wainwright 26th Annual Global Investment Conference September 9-11, 2024 - Nasdaq

NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) and HOPE Therapeutics, I - GuruFocus.com

NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) and HOPE Therapeutics, Inc. Announce Participation at the H.C. Wainwright 26th Annual Global Investment Conference September 9-11, 2024 - PR Newswire

NRXP Stock Earnings: NRX Pharmaceuticals Misses EPS for Q2 2024 - MSN

NRx Pharma Subsidiary HOPE Therapeutics Secures $30M to Buy Ketamine Clinics - citybiz

NRx Pharmaceuticals reports potential acquisition and financing agreements - MSN

HOPE Therapeutics secures $30 million for clinic acquisitions - Investing.com India

HOPE Therapeutics Secures Financing Ketamine Clinic ExpansionNRX Pharmaceuticals (NASDAQ:NRXP) - Benzinga

Plans for New Acquisition of Clinics Generating $100 Million - openPR

HOPE Therapeutics secures $30 million for clinic acquisitions - Investing.com

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Potential Acquisition and Financing Agreements for $30 Million in Currently-Operating Interventional Psychiatry Clinics - PR Newswire

NRx Pharmaceuticals begins search for new CEO - Investing.com

NRX Pharmaceuticals Seeks New CEO for Drug Launches - TipRanks

NRx Pharmaceuticals begins search for new CEO By Investing.com - Investing.com UK

NRx Pharmaceuticals, Inc. Announces Resignation of Stephen Willard as Chief Executive Officer - Marketscreener.com

NRx Pharmaceuticals Reports Second Quarter and Year-to-Date 2024 Financial Results and Business Update - MyChesCo

NRx Pharmaceuticals Secures $16 Million in Convertible Debt Financing - MSN

NRx Pharmaceuticals Secures $16 Million in Convertible Debt Financing - MyChesCo

NRx Pharmaceuticals Announces FDA Permission to Proceed on Inves - GuruFocus.com

NRx Pharmaceuticals to Report Second Quarter 2023 Financial Resu - GuruFocus.com

NRx Pharmaceuticals Provides Notice of Annual Meeting of Shareho - GuruFocus.com

NRx Pharmaceuticals (NASDAQ:NRXP) Issues Quarterly Earnings Results - Defense World

Earnings call: NRx Pharmaceuticals outlines key business advancements By Investing.com - Investing.com Australia

Earnings call: NRx Pharmaceuticals outlines key business advancements By Investing.com - Investing.com Canada

Earnings call: NRx Pharmaceuticals outlines key business advancements - Investing.com

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q2 2024 Earnings Call Transcript - Insider Monkey

Substantial Funding, Debt Resolution, HOPE Dividend, - openPR

NRXPNRx Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Participate in the EF Hutton Annual Global Conference on May 15, 2024 - Longview News-Journal

NRx Pharmaceuticals (NASDAQ:NRXP) Reports Second Quarter and Year to Date 2024 Financial Results and Provides Business Update - The Malaysian Reserve

NRx Pharmaceuticals : Announces First Successful Commercial Formulation for ZYESAMI™ (aviptadil), Enabling Volume Manufacture, Shipping, and Stockpiling of COVID-19 Medication Subject to Regulatory Approval - Marketscreener.com

NRx Pharmaceuticals (NASDAQ:NRXP) Reports Second Quarter and Year to Date 2024 Financial Results and Provides Business Update - PR Newswire

NRXP stock touches 52-week low at $1.86 amid market challenges - Investing.com

Ähnlich wie NRXP